The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study

被引:51
作者
Kohli, Indermeet [1 ]
Shafi, Rubina [2 ]
Isedeh, Prescilia [1 ]
Griffith, James L. [1 ]
Al-Jamal, Mohammed S. [1 ]
Silpa-archa, Narumol [1 ]
Jackson, Bradford [2 ]
Athar, Mohammed [2 ]
Kollias, Nikiforos
Elmets, Craig A. [2 ]
Lim, Henry W. [1 ]
Hamzavi, Iltefat H. [1 ]
机构
[1] Henry Ford Hosp, Dept Dermatol, Multicultural Dermatol Ctr, New Ctr One,3031 W Grand Blvd,Suite 800, Detroit, MI 48202 USA
[2] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL USA
关键词
colorimetry; cyclobutane pyrimidine dimers; excimer laser; minimal erythema dose; Polypodium leucotomos extract; sunburn cells; ultraviolet; VISIBLE-LIGHT; SKIN; ERYTHEMA; TRIAL; UVB; PIGMENTATION; PREVENTION; VITILIGO;
D O I
10.1016/j.jaad.2017.01.044
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: There is a rationale for adding systemic photoprotective agents to the current photoprotection regimen. Objective: This study was designed to objectively evaluate the molecular and photobiologic effects of oral administration of Polypodium leucotomos extract (PLE). Methods: In all, 22 subjects with Fitzpatrick skin phototype I to III were enrolled. On day 1, subjects were irradiated with visible light, ultraviolet (UV) A1, and UVB (using 308-nm excimer laser). Evaluation was done immediately and 24 hours after irradiation. On days 3 and 4, irradiation and evaluation process was repeated after ingestion of PLE. Results: Clinical assessments and colorimetry data showed a decrease in UVB-induced changes in 17 of 22 subjects post-PLE administration; histology findings demonstrated such a decrease in all 22 subjects. Limitations: Only 2 doses of PLE were given. Furthermore, subjects with skin phototypes I to III only were studied. Conclusion: The results suggest that PLE can potentially be used as an adjunctive agent to lessen the negative photobiologic effects of UVB.
引用
收藏
页码:33 / +
页数:10
相关论文
共 24 条
[1]   Benefits of oral Polypodium Leucotomos extract in MM high-risk patients [J].
Aguilera, P. ;
Carrera, C. ;
Puig-Butille, J. A. ;
Badenas, C. ;
Lecha, M. ;
Gonzalez, S. ;
Malvehy, J. ;
Puig, S. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (09) :1095-1100
[2]   Barriers to sun safety in a Canadian outpatient population [J].
Boggild, AK ;
From, L .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2003, 7 (04) :292-299
[3]  
Caccialanza M, 2011, GIORN ITAL DERMAT V, V146, P85
[4]   The role of antioxidants in photoprotection: A critical review [J].
Chen, Lucy ;
Hu, Judy Y. ;
Wang, Steven Q. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (05) :1013-1024
[5]  
Choudhry SZ, 2014, J DRUGS DERMATOL, V13, P148
[6]   Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure [J].
Duteil, Luc ;
Cardot-Leccia, Nathalie ;
Queille-Roussel, Catherine ;
Maubert, Yves ;
Harmelin, Yona ;
Boukari, Feriel ;
Ambrosetti, Damien ;
Lacour, Jean-Philippe ;
Passeron, Thierry .
PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (05) :822-826
[7]   The antioxidant action of Polypodium leucotomos extract and kojic acid:: reactions with reactive oxygen species [J].
Gomes, AJ ;
Lunardi, CN ;
Gonzalez, S ;
Tedesco, AC .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (11) :1487-1494
[8]   Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by Polypodium leucotomos [J].
Gonzalez, S ;
Pathak, MA .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 1996, 12 (02) :45-56
[9]  
Heras M. E. de las, 1997, Medicina Cutanea Ibero-Latino-Americana, V25, P103
[10]   A clinical trial and molecular study of photoadaptation in vitiligo [J].
Hexsel, C. L. ;
Mahmoud, B. H. ;
Mitchell, D. ;
Rivard, J. ;
Owen, M. ;
Strickland, F. M. ;
Lim, H. W. ;
Hamzavi, I. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (03) :534-539